Stanford Health Care
About Stanford Clinical LaboratoryLicensureContact Us

Home
Test Directory

Test Requisitions Specimen Collection
Critical Values
Administrative Department
Clinical DepartmentsDepartment of PathologyEsoteric DepartmentsFeatured Services



MGMT PROMOTER METHYLATION, BLOOD

Test Code: MGMTB
Description: Gliomas are the most common primary brain tumors. Presence of promoter methylation, which causes epigenetic silencing of the MGMT gene, a DNA repair gene on chromosome 10q26, is a positive predictive factor for chemotherapeutic response to alkylating agents in the treatment of gliomas. The methylation status of the MGMT promoter is determined by methylation-specific PCR analysis (MSP). The DNA is amplified with primers specific for the methylated and the unmethylated product.

 
 


 
Home | About Stanford Clinical Laboratories | Careers | Contact Us | Legal Notices & Disclaimer